UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
October 28, 2019
Inter Parfums, Inc.
(Exact name of Registrant as specified in its charter)
Delaware | | 0-16469 | | 13-3275609 |
(State or other jurisdiction of incorporation or organization) | | Commission File Number | | (I.R.S. Employer Identification No.) |
551 Fifth Avenue, New York, New York 10176
(Address of Principal Executive Offices)
212. 983.2640
(Registrant’s Telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 280.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 280.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 280.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§280.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
Common Stock, $.001 par value per share | | IPAR | | The Nasdaq Stock Market |
Item 2.02. Results of Operations and Financial Condition.
Certain portions of our press release dated October 28, 2019, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 2.02. They are as follows:
• | | The first headline relating to net sales for the third quarter of 2019 |
| | |
• | | Portions of the 1st paragraph relating to sales for the third quarter of 2019 |
• | | The 2nd paragraph (consisting of a table) relating to sales for the third quarter and the first nine months of 2019 |
• | | The 3rd paragraph relating to sales of European operations for the third quarter and first nine months of 2019 |
| | |
• | | The 4th paragraph relating to sales of United States operations for the third quarter of 2019 and first nine months of 2019 |
Item 7.01. Regulation FD Disclosure.
Certain portions of our press release dated October 28, 2019, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 7.01 and Regulation FD. They are as follows:
• | | The second headline relating to guidance |
| | |
• | | The last sentence of the 1st paragraph relating to the plans to issue results for the third quarter of 2019 on November 5, 2019 and initial guidance for 2020 on November 20, 2019 after the market closes |
• | | The 5th paragraph relating to proposed 2020 distribution and new product launch schedules |
| | |
• | | The 6th paragraph relating to 2019 guidance |
• | | The 8th paragraph relating to forward looking information |
• | | The balance of such press release not otherwise incorporated by reference in Item 2.02 |
Item 9.01 Financial Statements and Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.
Dated: October 28, 2019
| Inter Parfums, Inc. |
| |
| By: | /s/ Russell Greenberg |
| | Russell Greenberg, |
| | Executive Vice President |
| | and Chief Financial Officer |
2